LUMINOR THERAPEUTICS
Live / Allowed — Published for opposition (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 30 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99421187
- Mark type
- Stylized text
- Filed
- 30 Sept 2025
- Published for opposition
- 17 Mar 2026
- Attorney of record
- Adrienne Love
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of immune system related diseases and disorders, autoimmue diseases, cancer, inflammation and autoinflammation diseases by use of extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy and cellular therapies
- Class 010 — Medical apparatus: medical device, namely, therapeutic medical device for extracting blood from the body, separating blood, treating it extra corporally, and returning it to the body, used for extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies
- Class 042 — Scientific and technological services: Pharmaceutical research services; Pharmaceutical products development
- Class 044 — Medical, beauty and agricultural services: Medical and pharmaceutical consultation; medical services relating to extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies
Owner
- Therakos, LLC, Bridgewater, NJ, US
- Therakos, LLC, Bridgewater, NJ, US
Prosecution history
- 17 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Mar 2026 — PUBLISHED FOR OPPOSITION
- 11 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 20 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 20 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 20 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
- 19 Feb 2026 — ASSIGNED TO EXAMINER
- 10 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 30 Sept 2025 — NEW APPLICATION ENTERED